Safety & effectiveness study to evaluate if prophylactic left atrial appendage exclusion reduces occurrence of ischemic stroke or systemic embolism in cardiac surgery patients with elevated risk of stroke and no history of atrial fibrillation
Trial will evaluate the safety and effectiveness of AtriCure’s Isolator Synergy Clamp in conjunction with endocardial catheter ablation for the treatment of Inappropriate Sinus Tachycardia
Depending on the type of cardiac surgery, patients can have up to a 60% rate of occurrence of new onset post-op Afib (POAF).
Learn more about the risk factors and ways to manage POAF at: https://t.co/0mZcTthDZS#POAF#CardioTwitter#Afib
For many patients undergoing thoracic and cardiac procedures, managing pain during recovery can be challenging. Cryo Nerve Block offers a solution by temporarily blocking pain signals, helping patients experience a smoother, more comfortable recovery.
Discover #cryoNB at:… https://t.co/5g4YMDwtUo
At #AHA24, attendees explored the benefits of Hybrid AF™ Therapy and learned new data from the DEEP Trial, highlighting improved QOL for patients who underwent hybrid ablation and LAAE with an AtriClip® device.
Thank you to all the physicians who connected with us!
AtriClip® devices are the most widely implanted LAAM devices worldwide, setting the benchmark for innovation in appendage management. Our latest advancement, the AtriClip® FLEX-Mini™, is 60% smaller than the next lowest profile surgical #LAAM device on the market.
Learn more:… https://t.co/CjT51bbS3J
For many patients undergoing thoracic and cardiac procedures, managing pain during recovery can be challenging. Cryo Nerve Block offers a solution by temporarily blocking pain signals, helping patients experience a smoother, more comfortable recovery.
Discover Cryo Nerve Block at: https://okt.to/j5WRvI
Congratulations to Dr. Randolph H.L. Wong and the Prince of Wales Hospital team in Hong Kong on successfully completing their first case with the EPi-Sense® System! This milestone represents an important advancement in treating their Long-Standing Persistent Afib (LSPAF) patients.
Discover more about EPi-Sense: https://okt.to/nyuULN#HybridAFTherapy#CardiacSurgery#Cardiology
Depending on the type of cardiac surgery, patients can have up to a 60% rate of occurrence of new onset post-op Afib (POAF).
Learn more about the risk factors and ways to manage POAF at: https://okt.to/CK6oIy
#POAF#CardiacSurgery#Afib
For many patients undergoing thoracic and cardiac procedures, managing pain during recovery can be challenging. Cryo Nerve Block offers a solution by temporarily blocking pain signals, helping patients experience a smoother, more comfortable recovery.
Discover #cryoNB at: https://okt.to/CwLMOJ
#PainManagement
At #AHA24, attendees explored the benefits of Hybrid AF™ Therapy and learned new data from the DEEP Trial, highlighting improved quality of life for patients who underwent hybrid ablation and Left Atrial Appendage Exclusion (LAAE) with an AtriClip® device.
Thank you to all the physicians who connected with us, your collaboration is vital in driving innovation in Afib treatment!
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Healthcare Professionals. If you are a Patient or a Caregiver, please visit the 'Patients and Caregivers' page.
Click "Agree" to confirm you are a Healthcare Professional.
The information on this page is intended for Patients and Caregivers. If you are a Healthcare Professional, please visit the 'Healthcare Professionals' page.
Click "Agree" to confirm you are a Patient or a Caregiver.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Asia Pacific site
You are leaving the Asia Pacific site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Canada, Central & South America.
You are leaving the AtriCure Europe & Middle East site
You are leaving the Europe & Middle East site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in USA.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Asia Pacific.
You are leaving the AtriCure Canada, Central & South America site
You are leaving the Canada, Central & South America site of AtriCure.com and entering an AtriCure site intended for users in Europe & Middle East.
social media channels to keep updated on the latest at AtriCure.
Dorsey's Cardiac Testimonial
Duration: 3:44
Exclusion that Results in Electrical Isolation
Duration: 00:43
Blake’s Pectus Excavatum Full Journey
Duration: 6:29
About the 3D Heart Education App
Duration: 00:37